◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › Z › ZBH

Zimmer Biomet Holdings Inc (ZBH) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-09-19

Zimmer Biomet Holdings Inc (ZBH) operates in the Health Care Equipment industry and is headquartered in Warsaw, United States with about 17,000 employees. Its market capitalization is roughly $18 billion. In the fiscal year ended 2025-12-31, ZBH reported $8.2B in revenue and $705M in net income.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.

Interactive charts & full statements → Open the ZBH valuation workbench →

ZBH Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$8.5B	$8.2B	$7.7B	$7.4B	$6.9B	$6.8B	$6.1B	$8.0B	$7.9B	$7.8B	$7.7B	$6.0B	$4.7B	$4.6B	$4.5B	$4.5B	$4.2B	$4.1B	$4.1B	$3.9B	$3.5B
Gross Profit	$5.9B	$5.1B	$5.5B	$5.3B	$4.9B	$4.9B	$4.3B	$5.7B	$5.7B	$5.7B	$5.3B	$4.2B	$3.4B	$3.3B	$3.3B	$3.3B	$3.2B	$3.1B	$3.1B	$3.0B	$2.7B
Gross Margin %	69.9%	61.6%	71.5%	71.8%	70.9%	71.3%	70.2%	71.8%	71.4%	72.7%	68.9%	70.0%	73.4%	72.2%	74.8%	74.8%	76.0%	75.8%	75.8%	77.5%	77.7%
Operating Income (EBIT)	$1.4B	$1.4B	$1.3B	$1.3B	$696M	$860M	$83M	$1.1B	$34M	$799M	$821M	$467M	$1.0B	$1.0B	$1.0B	$1.0B	$917M	$1.0B	$1.1B	$1.1B	$1.2B
Operating Margin %	16.3%	16.6%	16.7%	17.3%	10.0%	12.6%	1.4%	14.2%	0.4%	10.2%	10.7%	7.8%	22.2%	22.4%	23.4%	23.0%	21.7%	24.9%	26.5%	28.9%	33.3%
Net Income	$807M	$705M	$904M	$1.0B	$231M	$402M	($139M)	$1.1B	($379M)	$1.8B	$306M	$147M	$720M	$761M	$755M	$761M	$597M	$717M	$849M	$773M	$834M
Net Margin %	9.5%	8.6%	11.8%	13.9%	3.3%	5.9%	-2.3%	14.2%	-4.8%	23.2%	4.0%	2.5%	15.4%	16.5%	16.9%	17.1%	14.1%	17.5%	20.6%	19.8%	23.9%
EBITDA	—	$2.2B	$2.3B	$2.2B	$1.5B	$1.6B	$1.0B	$2.1B	$1.1B	$1.9B	$1.8B	$1.2B	$1.4B	$1.4B	$1.4B	$1.4B	$1.3B	$1.5B	$1.4B	$1.4B	$1.4B
Earnings Per Share (EPS)	$4.11	$3.55	$4.43	$4.88	$1.10	$1.91	$-0.67	$5.47	$-1.86	$8.90	$1.51	$0.77	$4.20	$4.43	$4.29	$4.03	$2.97	$3.32	$3.72	$3.26	$3.40
Shares Outstanding (M)	—	199M	204M	210M	210M	210M	207M	207M	204M	204M	202M	190M	172M	172M	176M	189M	201M	216M	228M	238M	245M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ZBH Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	$2.2B	$2.1B	$2.2B	$2.0B	$2.1B	$1.9B	$2.0B	$1.8B	$1.9B
Gross Profit	$1.5B	$1.5B	$1.5B	$1.4B	$1.5B	$1.4B	$1.4B	$1.3B	$1.4B
Gross Margin %	70.8%	72.4%	64.7%	72.0%	71.5%	71.2%	71.0%	70.5%	71.5%
Operating Income (EBIT)	$374M	$373M	$288M	$351M	$300M	$292M	$389M	$280M	$351M
Operating Margin %	17.2%	17.9%	12.8%	17.5%	14.4%	15.3%	19.2%	15.3%	18.1%
Net Income	$198M	$238M	$140M	$231M	$153M	$182M	$240M	$249M	$243M
Net Margin %	9.1%	11.4%	6.2%	11.5%	7.4%	9.5%	11.8%	13.7%	12.5%
EBITDA	—	$538M	$454M	$638M	$576M	$550M	$614M	$536M	$596M
Earnings Per Share (EPS)	$1.03	$1.22	$0.70	$1.16	$0.77	$0.91	$1.20	$1.23	$1.18
Shares Outstanding (M)	—	196M	198M	199M	198M	200M	200M	203M	206M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ZBH Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$1.7B	$1.7B	$1.5B	$1.6B	$1.3B	$1.5B	$1.2B	$1.6B	$1.7B	$1.6B	$1.6B	$850M	$1.1B	$963M	$1.2B	$1.2B	$1.2B	$1.1B	$1.0B	$1.1B	$1.0B
Capital Expenditures (CapEx)	—	$224M	$357M	$394M	$188M	$152M	$118M	$405M	$163M	$156M	$185M	$168M	$145M	$100M	$115M	$114M	$88M	$265M	$597M	$331M	$268M
Free Cash Flow (FCF)	$1.3B	$1.5B	$1.1B	$1.2B	$1.1B	$1.3B	$1.1B	$1.2B	$1.6B	$1.4B	$1.4B	$682M	$916M	$863M	$1.0B	$1.1B	$1.1B	$853M	$441M	$753M	$772M
FCF Margin %	15.4%	17.9%	14.9%	16.1%	15.8%	19.7%	17.7%	14.8%	20.0%	18.3%	18.9%	11.4%	19.6%	18.7%	23.2%	23.9%	26.2%	20.8%	10.7%	19.3%	22.1%
Dividends Paid	—	$190M	$196M	$201M	$201M	$200M	$198M	$197M	$195M	$194M	$188M	$157M	$146M	$132M	$94M	$510M	$0M	$0M	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ZBH Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Cash from Operations (CFO)	$448M	$359M	$517M	$419M	$378M	$383M	$506M	$396M	$369M
Capital Expenditures (CapEx)	—	$36M	$151M	$127M	$80M	$47M	$85M	$27M	$146M
Free Cash Flow (FCF)	$331M	$323M	$366M	$292M	$298M	$336M	$421M	$369M	$223M
FCF Margin %	15.2%	15.5%	16.3%	14.6%	14.3%	17.6%	20.8%	20.2%	11.5%
Dividends Paid	—	$47M	$48M	$48M	$48M	$48M	$48M	$49M	$49M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ZBH Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$22.8B	$23.1B	$21.4B	$21.5B	$21.1B	$23.5B	$24.4B	$24.6B	$24.1B	$26.0B	$26.7B	$27.4B	$9.6B	$9.6B	$9.0B	$8.5B	$8.0B	$7.8B	$7.2B	$6.6B	$6.0B
Cash & Cash Equivalents	$410M	$592M	$526M	$416M	$376M	$378M	$802M	$618M	$543M	$524M	$634M	$1.5B	$1.1B	$1.1B	$884M	$768M	$669M	$692M	$213M	$464M	$266M
Total Liabilities	$10.2B	$10.4B	$8.9B	$9.0B	$9.0B	$10.8B	$12.2B	$12.2B	$12.9B	$14.3B	$17.0B	$17.6B	$3.1B	$3.3B	$3.1B	$3.0B	$2.2B	$2.1B	$1.6B	$1.2B	$1.1B
Total Debt (Short + Long-Term)	$7.5B	$7.5B	$6.2B	$5.9B	$5.7B	$7.1B	$8.1B	$8.2B	$8.9B	$10.1B	$11.2B	$23.1B	$1.5B	$1.7B	$1.8B	$1.7B	$1.1B	$1.1B	$460M	$104M	$100M
Total Shareholders' Equity	$12.6B	$12.7B	$12.5B	$12.5B	$12.0B	$12.7B	$12.2B	$12.4B	$11.3B	$11.7B	$9.7B	$9.8B	$6.5B	$6.3B	$5.9B	$5.5B	$5.8B	$5.6B	$5.7B	$5.5B	$4.9B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ZBH viewer.

ZBH Metric Deep Dives

Other Companies in Health Care Equipment

DXCM · Dexcom — $34 billion
RMD · ResMed — $32 billion
GEHC · GE HealthCare — $29 billion
STE · Steris — $20 billion
RVTY · Revvity — $16 billion
BAX · Baxter International — $12 billion
PODD · Insulet Corporation — $10 billion
ABT · Abbott Laboratories — $178 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← ZBAO All “Z” companies ZBIO →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.